IGF1-LR3 (Research Grade)

IGF-1 LR3 (Insulin-Like Growth Factor 1 Long R3) is a modified recombinant peptide currently under investigation for its interaction with cellular growth and metabolic signaling pathways. It is widely studied in experimental models exploring mechanisms related to peptide-mediated endocrine activity and prolonged receptor engagement.

Its structural modification contributes to extended activity in research settings, making it a relevant compound in advanced studies focused on cellular signaling, tissue-level processes, and systemic physiological regulation.

Cellexa Labs Standard
Supplied in high-purity, lyophilized form, IGF-1 LR3 is manufactured to ensure stability, consistency, and reliability across research applications.

Key Features

• ≥99% Purity
• Modified Recombinant Peptide
• Extended Activity Profile
• Lyophilized Powder Format
• Research-Grade Quality

Research Overview

IGF-1 LR3 is studied for its involvement in receptor-mediated pathways associated with cellular growth, metabolic regulation, and extended peptide signaling dynamics.

Disclaimer

For research purposes only. Not for human consumption.